← Back to home

PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI

Clinical trials for PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI explained in plain language.

Never miss a new study

Get alerted when new PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI trials appear

Sign up with your email to follow new studies for PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Yale tests 'Microdosing' magic mushrooms on the brain

Knowledge-focused Not yet recruiting

This small, early-stage study aims to understand if taking very small, non-psychedelic doses of psilocybin (from 'magic mushrooms') for 30 days can change mood, thinking skills, or brain activity. Researchers will compare 20 healthy adults who have never used psychedelics, giving…

Matched conditions: PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI

Phase: EARLY_PHASE1 • Sponsor: Yale University • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:31 UTC

PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI

Get alerted when new PSYCHEDELIC MICRODOSING EFFECTS ON MOOD, COGNITION, SUBJECTIVE WELL-BEING AND MRI trials appear

Yale tests 'Microdosing' magic mushrooms on the brain